Osivax
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
70 Rue Saint Jean Dieu, Lyon, Auvergne-R...Phone Number
+33 970301380Website
www.osivax.comRevenue
$7.8 MillionIndustry
About Osivax
Is Osivax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Osivax has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Osivax
Osivax, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Osivax is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Osivax had a recent Job posting/layoffs
Product Launch: Get notified when Osivax launches new products
Earning: See what the market has to say on Osivax recently announced quarterly report
Funding: Get notified immidiatlly once Osivax has new funding data
Recommended Actions
Reach out to Masked Content who joined Osivax as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Osivax is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Osivax is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Osivax.
Osivax financials insights
Gather financial insights about Osivax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$6.5M
Series A
$8.8M
Series B
$10.8M
Other Financing Round
$19.5M
Osivax Tech Stack
A closer look at the technologies used by Osivax
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Osivax
Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOMTM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses.Osivax’s ambition is to develop a pan-respiratory... Read More